Literature DB >> 14675538

Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E.

John D Gross1, Nathan J Moerke, Tobias von der Haar, Alexey A Lugovskoy, Alan B Sachs, John E G McCarthy, Gerhard Wagner.   

Abstract

The eukaryotic initiation factor 4G (eIF4G) is the core of a multicomponent switch controlling gene expression at the level of translation initiation. It interacts with the small ribosomal subunit interacting protein, eIF3, and the eIF4E/cap-mRNA complex in order to load the ribosome onto mRNA during cap-dependent translation. We describe the solution structure of the complex between yeast eIF4E/cap and eIF4G (393-490). Binding triggers a coupled folding transition of eIF4G (393-490) and the eIF4E N terminus resulting in a molecular bracelet whereby eIF4G (393-490) forms a right-handed helical ring that wraps around the N terminus of eIF4E. Cofolding allosterically enhances association of eIF4E with the cap and is required for maintenance of optimal growth and polysome distributions in vivo. Our data explain how mRNA, eIF4E, and eIF4G exists as a stable mRNP that may facilitate multiple rounds of ribosomal loading during translation initiation, a key determinant in the overall rate of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14675538     DOI: 10.1016/s0092-8674(03)00975-9

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  147 in total

1.  Acute regulation of translation initiation by gonadotropin-releasing hormone in the gonadotrope cell line LbetaT2.

Authors:  Kathryn A Nguyen; Sharon J Santos; Marit K Kreidel; Alejandro L Diaz; Rodolfo Rey; Mark A Lawson
Journal:  Mol Endocrinol       Date:  2004-01-29

Review 2.  Translational regulation in nutrigenomics.

Authors:  Botao Liu; Shu-Bing Qian
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

3.  The eukaryotic initiation factor (eIF) 4G HEAT domain promotes translation re-initiation in yeast both dependent on and independent of eIF4A mRNA helicase.

Authors:  Ryosuke Watanabe; Marcelo Jun Murai; Chingakham Ranjit Singh; Stephanie Fox; Miki Ii; Katsura Asano
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

4.  Local control of a disorder-order transition in 4E-BP1 underpins regulation of translation via eIF4E.

Authors:  Shirley Tait; Kaushik Dutta; David Cowburn; Jim Warwicker; Andrew J Doig; John E G McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-28       Impact factor: 11.205

5.  The 5'-7-methylguanosine cap on eukaryotic mRNAs serves both to stimulate canonical translation initiation and to block an alternative pathway.

Authors:  Sarah F Mitchell; Sarah E Walker; Mikkel A Algire; Eun-Hee Park; Alan G Hinnebusch; Jon R Lorsch
Journal:  Mol Cell       Date:  2010-09-24       Impact factor: 17.970

Review 6.  Eukaryote-specific extensions in ribosomal proteins of the small subunit: Structure and function.

Authors:  Arnab Ghosh; Anton A Komar
Journal:  Translation (Austin)       Date:  2015-02-05

Review 7.  Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

Authors:  Nahum Sonenberg; Alan G Hinnebusch
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 8.  eIF4E: new family members, new binding partners, new roles.

Authors:  Robert E Rhoads
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

9.  Mobility of TOAC spin-labelled peptides binding to the Src SH3 domain studied by paramagnetic NMR.

Authors:  Hanna E Lindfors; Peter E de Koning; Jan Wouter Drijfhout; Brigida Venezia; Marcellus Ubbink
Journal:  J Biomol NMR       Date:  2008-06-17       Impact factor: 2.835

10.  Cap-binding activity of an eIF4E homolog from Leishmania.

Authors:  Yael Yoffe; Joanna Zuberek; Magdalena Lewdorowicz; Ziv Zeira; Chen Keasar; Irit Orr-Dahan; Marzena Jankowska-Anyszka; Janusz Stepinski; Edward Darzynkiewicz; Michal Shapira
Journal:  RNA       Date:  2004-09-23       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.